Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer

NCT04193059 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1560

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Docetaxel

Sponsor

Fudan University